文献速递血液净化与透析

Klotho 通过抑制 Wnt 信号通路成为腹膜纤维化新型治疗靶点

Klotho is a novel therapeutic target in peritoneal fibrosis via Wnt signaling inhibition.
PubMed 文献 · Nephrol Dial Transplant · 2020-01-01

该研究探讨 Klotho 蛋白通过抑制 Wnt/β-catenin 信号通路减轻腹膜纤维化的作用。研究使用 β-catenin 激活转基因报告小鼠、Klotho 转基因小鼠和野生型小鼠,每日腹腔注射 4.25% 葡萄糖透析液或生理盐水 4 周。结果显示,野生型小鼠腹膜透析后 Wnt 信号激活、腹膜纤维化加速,而 Klotho 转基因小鼠 Wnt/β-catenin 信号激活减弱、腹膜纤维化进展减轻。结论:Klotho 过表达通过减弱 Wnt/β-catenin 信号通路保护腹膜,重组 Klotho 蛋白可能成为腹膜纤维化的新型治疗靶点。

要点

  • 腹膜透析后腹膜间皮细胞 Wnt 信号激活并加速纤维化。
  • Klotho 转基因小鼠可减弱 Wnt/β-catenin 信号并减轻腹膜纤维化。
  • 重组 Klotho 蛋白可能是腹膜纤维化的潜在治疗靶点。

核心结论

  • Klotho 蛋白过表达通过减弱 Wnt/β-catenin 信号通路保护腹膜,重组 Klotho 蛋白可能成为腹膜纤维化的新型治疗靶点。

研究设计与样本

  • 使用 β-catenin 激活转基因报告小鼠(BAT-LacZ)、Klotho 转基因小鼠(KLTG,C57BL/6 背景)和野生型 C57BL/6 小鼠。
  • 小鼠每日腹腔注射 4.25% 葡萄糖含乳酸盐腹膜透析液或生理盐水作为对照,持续 4 周;另有小鼠每日腹腔注射等体积生理盐水作为正常对照。

主要发现

  • 野生型小鼠腹膜透析后腹膜间皮细胞出现 Wnt 信号激活,腹膜纤维化加速,β-catenin 和 Wnt 诱导基因蛋白表达显著增加。
  • Klotho 转基因小鼠腹膜透析后 Wnt/β-catenin 信号激活减弱,腹膜纤维化进展减轻。

临床怎么用

  • 重组 Klotho 蛋白可能作为腹膜纤维化的新型治疗靶点,但尚需进一步临床研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Long-term exposure to bioincompatible peritoneal dialysate causes the loss of mesothelial cells and accumulation of matrix proteins, leading to an increase in the thickness of the submesothelial layer, thereby limiting the long-term effectiveness of peritoneal dialysis (PD). However, the detailed molecular mechanisms underlying the process of peritoneal fibrosis have not been clearly elucidated. Wnt/β-catenin signaling pathway activation has been suggested to play a pivotal role in the development of organ fibrosis. Moreover, Klotho protein can regulate Wnt/β-catenin signaling. We examined the role of Klotho protein in reducing peritoneal fibrosis by inhibiting Wnt/β-catenin signaling. METHODS: The β-catenin-activated transgenic (BAT) driving expression of nuclear β-galactosidase reporter transgenic (BAT-LacZ) mice, the alpha-Klotho gene under control of human elongation factor 1 alpha promoter [Klotho transgenic (KLTG) and C57BL/6 background] and C57BL/6 mice [wild-type (WT)] were used. The mice received daily intraperitoneal (i.p.) injections of 4.25% glucose with lactate (PD solution) or saline as a control for 4 weeks. Other mice received daily i.p. injections of the same volume of saline (normal control). RESULTS: After exposure to PD, Wnt signal activation was observed on the peritoneal mesothelial cells in WT-PD mice. The peritoneal fibrosis was also accelerated in WT-PD mice. The protein expression of β-catenin and Wnt-inducible genes were also remarkably increased in WT-PD mice. On the other hand, KLTG-PD mice attenuated activation of Wnt/β-catenin signaling after exposure to PD and ameliorated the progression of peritoneal fibrosis. CONCLUSIONS: Overexpression of Klotho protein protects the peritoneal membrane through attenuation of the Wnt/β-catenin signaling pathway. The availability of recombinant Klotho protein would provide a novel potential therapeutic target in peritoneal fibrosis.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Kadoya H, Satoh M, Nishi Y, et al. Klotho is a novel therapeutic target in peritoneal fibrosis via Wnt signaling inhibition. Nephrol Dial Transplant. 2020. PMID: 32221606. doi:10.1093/ndt/gfz298

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。